iddst2024CN
Scientific Program

——————      Final Program     ——————

 

The detailed meeting agenda is available at:  https://www.iddst.com/iddst2024cn/schedule.asp

 

  *  Please keep your speech PPT both in USB drive and email address, no need to send it to the conference side
  ** Please arrive at the meeting room priori to 20-30 minutes before the session and copy the PPT slides to the computer by yourself
  *** The speech is 20-25 min including Q&A time

  **** The screen ratio is 16:9, please prepare your PPT according to this

 

Registration

Time: 10:00-21:00, September 11, 2024 (Wednesday); Place: Lobby, 2nd Floor, Nanjiao Hotel Shanghai

 

Opening Ceremony

Time: 08:30-09:10, September 12, 2024 (Thursday); Place: Huachang Hall, 1st Floor, Nanjiao Hotel Shanghai

 

Plenary Session and High-end Dialogue

Time: 09:10-12:30, September 12, 2024 (Thursday); Place: Huachang Hall, 1st Floor, Nanjiao Hotel Shanghai

 

Moderator

Dr. Ao Zhang, Dean and Distinguished Professor, College of Pharmaceutical Sciences, Shanghai Jiao Tong University, China

 

09:10-09:15

Moderator's Introduction

09:15-09:35

Title: Drug Discovery Targeting KRAS

Dr. Ao Zhang, Dean and Distinguished Professor, College of Pharmaceutical Sciences, Shanghai Jiao Tong University, China

09:35-09:55

Title: AI-Driven De Novo Design for Discovery of Potential Drug Candidates Targeting SARS-CoV-2 Main Protease

Dr. Alexander Tuzikov, Professor, United Institute of Informatics Problems, National Academy of Sciences of Belarus, Belarus

09:55-10:15

Title: Discovery and Biosynthesis of Anti-infective Natural Productsfrom Marine Microorganisms

Dr. Jianhua Ju, Dean, School of Pharmaceutical Sciences, Shandong University, China

10:15-10:35

Title: Medical and Industrial Integration Promotes the Progress and Transformation of Theranostics Techniques for Digestive Tract Diseases

Dr. Daxiang Cui, Academic Vice President and Dean of the School of Medicine, Henan University, China

10:35-10:55

Title: Getting Enzyme Biotechnology into the Fibers of Modern Society

Dr. Jens Erik Nielsen, Senior Vice President, Enzyme, Protein and Strain Engineering Research, Novonesis A/S, Denmark 

10:55-11:15

Title: Development of Drugs for Respiratory Viral Infections Utilizing AI-driven Pharmaceutical Models
Dr. Xumu Zhang, Dean, Medi-X Pingshan of SUSTech, China

11:15-11:35

Title: Blocking C5a/C5aR1 Pathway - A Powerful Tool to Control Inflammation

Dr. Renfeng Guo, CSO, Inflarx Pharmaceutical Inc., USA & Adjunct Associate Professor, University of Michigan Medical School, USA

11:35-11:55

Title: BL-602, a Cyclophilin Inhibitor, Reduces Fibrosis and Proteinuria in Chronic Kidney Disease
Dr. Dan Wang, Senior Director of Formulation and Regulatory Affairs, Shanghai Medicilon Inc., China

12:00-12:30

High-end Dialogue (Part I)

Moderator: Dr. John Xu, President, BIORICH International, USA 

Topic: The Future of Biopharma: Navigating Innovation, Regulation, and Global

Collaboration

Guest Speakers:

Dr. Lianshan Zhang, Vice General Manager & Global R&D President, Jiangsu

Hengrui Pharmaceuticals Co., Ltd., China 

Dr. Shuangqing Peng, Chief Scientific Officer, Shanghai Medicilon Inc., China

Dr. Hongyan Xu, CEO/President, GL Biochem (Shanghai) Ltd.,China

Dr. Jizong Li, Director, Shanghai Center of Biomedicine Development, China

 

High-end Dialogue (Part II)

Moderator: Dr. John Xu, President, BIORICH International, USA 

Topic: Frontier Technologies and Innovative Breakthroughs in Biotherapy

Guest Speakers:

Dr. Yusheng Wu, Chair/CEO/Founder, TYK Medicines, Inc, China

Dr. Yinsheng Zhang, CSO, Wuxi Beita PharmaTech Co., Ltd., China 

Dr. Gary Xiao, President, Shenzhen Weilan Academy for Translational Medicine,

China

Dr. Yong Qian, Chairman,BioMedicure, USA & China

 

  

 

Track 1: Innovative Drug Discovery Science and Technology

 

IDDST 01: Target Identification & Validation

Time: 14:00-17:40, September 12, 2024 (Thursday); Place: Room 5A, 1st Floor, Nanjiao Hotel Shanghai

Chair

Dr. Thomas Wittlinger, Professor, Department of Cardiology, Asklepios Hospital, Germany

Co-chair

Dr. Narsimha Reddy, Associate Director of Academic Program, School of Science, Western Sydney University, Australia 

14:00-14:05

Chair's Introduction

14:05-14:30

 

Title: Novel Target Discovery and Transformative Therapies for Solid Tumors
Dr. Stefan Scherer, CEO and President, 3TBiosciences, USA

14:30-14:55

Title: Clustering Inflammatory Markers with Sociodemographic and Clinical Characteristics of Patients with Diabetes Type 2
Dr. Thomas Wittlinger, Professor, Department of Cardiology, Asklepios Hospital, Germany

14:55-15:20

 

Title: The Unique Properties of E2F in Specifically Targeting Cancer Cells
Dr. Yaxuan Zhou, Kwansei Gakuin University, Japan

15:20-15:45

 

Title: Therapeutic Peptides: Paving the Way from Research to Innovative Drugs for Metabolic Diseases
Dr. Ved Srivastava, CTO, Perpetual Medicines, Raleigh NC, USA

15:45-16:00

Coffee Break

16:00-16:25

Title: Towards the Discovery of Novel Immunomodulatory and Anticancer Polysaccharides from Traditional Medicinal Plants/Mushrooms

Dr. Narsimha Reddy, Associate Director of Academic Program, School of Science, Western Sydney University, Australia 

16:25-16:50

Title: Development and Validation of a Novel Risk Score to Predict 5-Year Mortality in Patients with Acute Myocardial Infarction in China: A Retrospective Study

Dr. Yan Tang, Attending Physician, The First Affiliated Hospital of Nanchang University, China

16:50-17:15

Title: Mast Cells as a Potential Target of Molecular Hydrogen in Regulating the Local Tissue Microenvironment

Dr. Dmitrii Atiakshin, Director of the Scientific and Educational Resource Center "Innovative Technologies of Immunophenotyping, Digital Spatial Profiling and Ultrastructural Analysis", RUDN University, Russia

17:15-17:40

Title: Breakthrough Findings Demonstrate That Namodenoson Anti-cancer and Liver Protective Effects Are Mediated via Adiponectin  (Video Speech)
Dr. Pnina Fishman, CSO & Executive Chairman, Can-Fite Biopharma Ltd., Israel

 

IDDST 02: Disease Models & Applications

Time: 14:00-18:05, September 12, 2024 (Thursday); Place: Room 5B, 1st Floor, Nanjiao Hotel Shanghai

Chair

Dr. Anil K. Agarwal, Associate Professor of Prosthodontist, Northwestern University, USA

Co-chair

Dr. Dazhi Liu, Professor, University of California at Davis, USA

14:00-14:05

Chair's Introduction

14:05-14:30

 

Title: Animal Models of Human Diseases and the Application in Pharmacodynamic Studies
Dr. Yunyun Yuan, Project Manager, Shanghai Medicilon Inc., China

14:30-14:55

Title: Tumor Suppressor MicroRNA Thearapeutics for Traumatic Brain Injury
Dr. Dazhi Liu, Professor, University of California at Davis, USA

14:55-15:20

 

Title: MIND and Its Magic
Dr. Anil K. Agarwal, Associate Professor of Prosthodontist, Northwestern University, USA

15:20-15:45

 

Title: Adolescent Pre-treatment with the Selective Cannabinoid 1 Receptor Agonist May Lead to Abnormal Hippocampal Theta Synchronization in Adulthood
Dr. Bernat Kocsis, Associate Professor, Harvard Medical School, USA

15:45-16:00

Coffee Break

16:00-16:25

Title: Application of Immunofluorescence Mapping in the Diagnosis of Dystrophic Epidermolysis Bullosa
Dr. Wei Melbourne, Senior Scientist, St. George Hospital UNSW Sydney, Australia

16:25-16:50

Title: Novel Therapeutic Low Molecular Weight Antibodies for Treatment of Aggressive Esophageal Adenocarcinoma with SMAD4 Loss
Dr. Kausilia K. Krishnadath, Professor, University of Antwerp, Belgium

16:50-17:15

Title: Creation Panel of Primary Breast Cancer Cell Lines as New Cancer Model for Drug Screening and Basic Research
Dr. Xiaowei Dou, Research Associate, Clinical Research Center, The Affiliated Hospital of Guizhou Medical University, China

17:15-17:40

Title: Glycyrrhizic Acid Inhibits SARS-CoV-2 Infection by Blocking Spike Protein-Mediated Cell Attachment
Dr. Lingling Wang, Lecturer, Xihua University, China

17:40-18:05

Title: Demyelination and Inflammation of CNS are Suppressed by Astragalus Polysaccharides in Experimental Autoimmune Encephalomyelitis Mediated via the PD-1/PD-Ls Pathway

Dr. Xiaodong Cheng, Professor & Director, Institute of Clinical Immunology, Yue-Yang Hospital of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, China

 

IDDST 03: Drug Discovery Chemistry & Targeted Drug Delivery

Time: 08:30-12:35, September 13, 2024 (Friday); Place: Room 5A, 1st Floor, Nanjiao Hotel Shanghai

Chair

Dr. Maliha Zahid, Associate Professor, Mayo Clinic, USA

Co-chair

Dr. Hongbo Zhang, Professor of Fluid Mechanics, East China University of Science and Technology, China

08:30-08:35

Chair's Introduction

08:35-09:00

 

Title: Current Challenges and Control Strategies for Polysorbate Degradation in Biopharmaceuticals
Dr. Bo Meng, Associate Director, China & APAC CMC Management, WuXi Biologics, China

09:00-09:25

 

Title: In Vitro Models by the 3D Bioprinting Coupled with the Organ on a Chip Technology
Dr. Hongbo Zhang, Professor of Fluid Mechanics, East China University of Science and Technology, China

09:25-09:50

 

Title: Novel Ester Type Catechins: Chemical Truth and Mechanisms of the Anti-aging Effects of Green Tea
Dr. Guanhu Bao, Professor, Anhui Agricultural University, China 

09:50-10:15

 

Title: Natural Products from Chinese Herbal Medicine: From a Treasure House to Promising Anticancer Leads

Dr. Lijuan Deng, Associate Professor, Jinan University, China

10:15-10:30

Coffee Break

10:30-10:55

 

Title: Cardiac Targeting Peptide: From Discovery to Applications
Dr. Maliha Zahid, Associate Professor, Mayo Clinic, USA

10:55-11:20

 

Title: Molecular Modelling of Surface Viral Proteins for the Development of Broad-Spectrum Antiviral Drugs
Dr. Sophia S. Borisevich, Senior Researcher, Ufa Institute of Chemistry UFRC RAS, Russia

11:20-11:45

 

Title: Peptide-Drug Conjugates: Design, Chemistry and Targeted Drug Delivery with Improved Therapeutic Potential

Dr. Syed Faheem Askari Rizvi, Postdoctoral Fellow, Lanzhou University, China

11:45-12:10

 

Title: Exploring the Potential of Triazenes: Antimalarial Activity and Antimicrobial Potential

Dr. Frans J. Smit, Senior Lecturer, North-West University, South Africa 

12:10-12:35

Title: Sustainable γ-Cyclodextrin Frameworks Containing Ultra-Fine Silver Nanoparticles with Enhanced Antimicrobial Efficacy
Dr. Vikramjeet Singh, Assistant Professor, University College London, UK

 

IDDST 04: Pipelines & Clinical Applications

Time: 13:30-17:10, September 13, 2024 (Friday); Place: Room 5A, 1st Floor, Nanjiao Hotel Shanghai

 

Chair

Dr. Adel K. El-Naggar, Professor, University of Texas, MD Anderson Cancer Center, USA

Co-chair

Dr. Xiaolei Zhu, Assistant Professor, Johns Hopkins University, USA

13:30-13:35

Chair's Introduction

13:35-14:00

Title: Discovery and Development of Dual Inhibitors of MDM2 and XIAP for Cancer Therapy
Dr. Muxiang Zhou, Professor, Emory University School of Medicine, USA

14:00-14:25

Title: Anestral Evolution and Genomic Heterogeneity of Salivary Adenoid Cystic Carcinoma: Biological and Therapeutic Implications

Dr. Adel K. El-Naggar, Professor, University of Texas, MD Anderson Cancer Center, USA

14:25-14:50

Title: Treatment of Malaria and COVID 19: It Is Never Too Late
Prof. Dr. Dr. Rolf G. Werner, COO, Jiangsu Pacific Meinuoke Biopharmaceutical, China; Honorary Senator and Professor, Industrial Biotechnology, University of Tubingen, Germany

14:50-15:15

Title: Pharmacovigilance in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
Dr. Omer M. Iqbal, Research Professor, Loyola University Stritch School of Medicine, USA

15:15-15:30

Coffee Break

15:30-15:55

Title: Novel Microglial-Targeted Glutaminase Inhibitors for Chronic Stress-Associated Depression
Dr. Xiaolei Zhu, Assistant Professor, Johns Hopkins University, USA

15:55-16:20

Title: Pgk1 Activators May as a Potential Strategy for Treating Various Neurodegenerative Diseases
Dr. Rong Cai, Assistant Professor, School of Engineering Medcine, Beihang University, China

16:20-16:45

Title: DEAD-Box RNA Helicase DP103 Regulated SUMO/Acetylation Switch of p53 Determines Response to Docetaxel in ERα-Positive Breast Cancer
Dr. Alan P. Kumar, Assistant Professor, National University of Singapore, Singapore 

16:45-17:10

Title: Cardiolipin Oxidized by ROS from Complex II Acts as a Target of Gasdermin D to Drive Mitochondrial Pore and Heart Dysfunction in Endotoxemia

Dr. Yan Tang, Attending Physician, The First Affiliated Hospital of Nanchang University, China

 

IDDST 05: Disruptive Technologies & Integrative Services for Pharmaceutical Manufacturing

Time: 08:30-12:10, September 14, 2024 (Saturday); Place: Room 5A, 1st Floor, Nanjiao Hotel Shanghai

 

Chair

Dr. Songhai Chen, Associate Professor, University of Iowa, USA

Co-chair

Dr. Robert Marks, Professor, Ben-Gurion University of the Negev, Israel

08:30-08:35

Chair's Introduction

08:35-09:00

Title: AI-Driven Cancer Precision and Therapy

Dr. Gary Xiao, President, Shenzhen Weilan Academy for Translational Medicine, China

09:00-09:25

Title: The Extensive Utilization of Isotope-Labeled Compounds in Pharmaceutical R&D

Dr. Yinsheng Zhang, CSO, Wuxi Beita PharmaTech Co., Ltd., China

09:25-09:50

Title: Unveiling GPCR Signaling as a Therapeutic Target in Breast Cancer
Dr. Songhai Chen, Associate Professor, University of Iowa, USA

09:50-10:15

Title: A Study in Instant Mass Analysis for Shortening Experimental Cycles in Drug Discovery

Dr. Janshon Zhu, President & CTO, RangerBio Technologies, Ltd. Co., China

10:15-10:30

Coffee Break

10:30-10:55

Title: Cap-ImAb – A Platform Enzyme-Based Immunoassay for Determination of Anti-drug Antibodies and Related Immunogenicity in Patients Receiving Biologic Therapy

Dr. Robert Marks, Professor, Ben-Gurion University of the Negev, Israel

10:55-11:20

Title: ICH Q14 and USP Chapter <1220>: Historical Perspective and the Path Forward in Analytical QbD
Dr. Horacio Pappa, Senior Director of General Chapters, Global Science and Standards Division, United States Pharmacopeia, USA

11:20-11:45

Title: Paradigm Shifts in the Evolving Pharmaceutical Landscape: Perspectives from the USP
Dr. Horacio Pappa, Senior Director of General Chapters, Global Science and Standards Division, United States Pharmacopeia, USA

11:45-12:10

Title: Artificial Intelligence in Drug Safety Monitoring
Dr. Peter Hangping Zhang, Executive Director, Acadia Pharmaceuticals, Inc., USA

 

 

Track 2: New Strategies and Techniques for Anti-tumor Diagnosis and Treatment

 

WCC 01: Breakthroughs in Cancer Research

Time: 14:00-17:20, September 12, 2024 (Thursday); Place: Room 6, 1st Floor, Nanjiao Hotel Shanghai

 

Chair

Dr. Yong Qian, Chairman,BioMedicure, USA & China

Co-Chair

Dr. Yong Li, Professor, Baylor College of Medicine, USA

 

14:00-14:05

Chair's Introduction

14:05-14:25

Title: Mechanisms Underlying Heterogeneous Outcome of Immune Checkpoint Inhibitors in Mouse HNSCC Models
Dr. Jing H. Wang, Professor, UPMC Hillman Cancer Center, University of Pittsburgh, USA

14:25-14:45

Title: MHC Class-I Independent Activation of a Subset of CD8 T Cells Induced by Chemotherapeutic Agent-Treated Cancer Cells
Dr. Zhangguo Chen, Research Associate Professor, University of Pittsburgh, UPMC Hillman Cancer Center, USA

14:45-15:05

Title: Modified Technique 'Modus Spirdonov 1' in Fine-Needle Aspiration Biopsy Under Ultrasonographical Control

Dr. Yordan Spirdonov, University Hospital 'Queen Joanna - ISUL', Bulgaria

15:05-15:25

Title: The Matrix Metalloproteinases Expression in the Hypoxic Microenvironment

Dr. Gonzalez-Avila Georgina, Head of the Chronic Degenerative Diseases Research Department and the Laboratory of Biomedical Oncology, Instituto Nacional de Enfermedades Respiratorias 'Ismael Cosío Villegas' , Mexico

15:25-15:45

Title: DNA Vaccines for Cancer Prevention and Therapy
Dr. Yong Li, Professor, Baylor College of Medicine, USA

15:45-16:00

Coffee Break

16:00-16:20

Title: Electric Fields Regulate in Vitro Surface Phosphatidylserine Exposure of Cancer Cells via a Calcium-Dependent Pathway
Dr. Xiaoyang Qi, Professor, University of Cincinnati College of Medicine, USA

16:20-16:40

Title: A New Tumor Marker that can Work as a Diagnostic And Therapeutic Target for Digestive System Neoplasm

Dr. Fangfang Chen, Professor, China-Japan Union Hospital of Jilin University, China

16:40-17:00

Title: Universal Cancer Only Marker(UCOM) Discovery and Application for Early Tumor Specific DNA Methylation Detectionr Screening and Detection

Dr. Wenqiang Yu, Professor, Institutes of Biomedical Sciences of Fudan University, China

17:00-17:20

Title: Understanding Human Health and Diseases with One's Immune System Evolution
Dr. Yong Qian, Chairman,BioMedicure, USA & China

 

WCC 02: Clinical Oncology

Time: 08:30-12:30, September 13, 2024 (Friday); Place: Room 6, 1st Floor, Nanjiao Hotel Shanghai

 

Chair

Dr. Pier Paolo PiccalugaProfessor, Universita degli Studi di BolognaI, Italy

Co-Chair

Dr. Ulrike Stein, Professor, Charite University Medicine Berlin, Germany

 

08:30-08:35

Chair's Introduction

08:35-08:55

Title: Emerging Concepts in Immune Oncology

Dr. Catalin Mihalcioiu, Assistant Professor, McGill University Health Centre ( MUHC), Canada

08:55-09:15

Title: Tumor-derived miR-181a-5p-containing Extracellular Vesicles Promote M2-polarization of Macrophage to Secret Taurine for Suppressing Ferroptosis in Prostate Cancer

Dr. Yu-Xiang Fang, Associated Investigator, Shanghai Jiao Tong University, China

09:15-09:35

Title: FOXA1 Prolongs S Phase and Promotes Cancer Progression in Non-Small Cell Lung Cancer Through Upregulation of CDC5L and Activation of the ERK1/2 and JAK2 Pathways
Dr. Rui-Shi Wei, Professor, Dalian Medical University, China

09:35-09:55

Title: Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, Statistics and Modeling for Optimal Management

Dr. Oleg Kshivets, Head of Surgery Department, Consultant Thoracoabdominal Surgeon and Surgical Oncologist, Bagrationovsk Hospital, Kaliningrad Oblast, Russia

ǩ֤ʧ��

09:55-10:15

Title: Cancer Preventive Properties of an Anthocyanin-Enriched Sweetpotato in the APCMIN Mouse Model
Dr. Khalid Asadi, Research Scientist, The University of Auckland, New Zealand

10:15-10:30

Coffee Break

10:30-10:50

Title��Efficacy and Safety of Caspofungin for Patients with Hepatic Insufficiency

Dr. Xiaoyun Ran, Physician in the Department of Critical Medicine, The Second Affiliated Hospital of Chongqing Medical University, China

10:50-11:10

Title: Restrict Cancer Metastasis: Translating Gene Discovery into Clinical Application

Dr. Ulrike Stein, Professor, Charite University Medicine Berlin, Germany

11:10-11:30

Title: Supine or Prone MDCT Position for Breast Cancer Staging when MRI is Unavailable? A Clinical Study

Dr. Yordan Spirdonov, University Hospital 'Queen Joanna - ISUL', Bulgaria

11:30-11:50

Title: Classification of Malignant Lymphomas

Dr. Pier Paolo Piccaluga, Associate Professor, Bologna University School of Medicine, Italy

11:50-12:10

Title: Conditional Reprogramming Modeling of Bladder Cancer for Clinical Translation 
Dr. Xuefeng Liu, Professor, The Ohio State University, USA

12:10-12:30

Title: Immune Self Nano for Cancer Clinical Therapy
Dr. Baofa Yu, President, Shandong Baofa Cancer Research Institute, China

 

WCC 03: Novel Cancer Therapeutics

Time: 08:30-12:10, September 14, 2024 (Saturday); Place: Room 6, 1st Floor, Nanjiao Hotel Shanghai

 

Chair

Dr. Ruola Ning, Professor, University of Rochester, USA

Co-Chair

Dr. Tao Lu, CEO, OmniGenex, LLC. USA

 

08:30-08:35

Chair's Introduction

08:35-09:00

Title: Cone Beam Breast CT – A Precision Medicine Tool for Breast Cancer Detection, Diagnosis and Image-Guided Treatment

Dr. Ruola Ning, Professor, University of Rochester, USA

09:00-09:25

Title: DP-independent E2F Activity as a Target of Cancer Specific Therapeutics

Dr. Rinka Nakajima, Kwansei Gakuin University, Japan

09:25-09:50

Title: Side Effects Alleviation of Chemotherapy with Chinese Herbal Medicine

Dr. Chi-Feng Cheng, Director, Taipei City United Hospital, Taiwan

09:50-10:15

Title: Novel Antagonistic Anti-PD-1 Antibodies not Blocking the PD-1-PDL-1 Interaction with Potent Anti-Tumor Activity

Dr. Giuseppe Pantaleo, Professor, Lausanne University Hospital, Switzerland

10:15-10:30

Coffee Break

10:30-10:55

Title: IL-8, A Tumor Microenvironmental Factor, Promotes Prostate Cancer Progression and Therapeutic Resistance

Dr. Yong Xu, Professor, Nanjing Medical University, China

10:55-11:20

Title: Anticancer Potentials and Interactome of Bioactive Ingredients in Food-Medicine-Homologous Fruits of Docynia Delavayi, Rosaceae

Dr. Phoency F.H. Lai, Professor, University of Shanghai for Science and Technology, China

11:20-11:45

Title: Targeting p53 in Cancer: How Many Angles and How Many Layers?

Dr. Tao Lu, CEO, OmniGenex, LLC. USA

11:45-12: 10

Title: High-Resolution Whole-Body Positronium Lifetime Imaging

Dr. Jinyi Qi, Professor, University of California, Davis, USA

 

Track 3: Antibodies, Vaccines and Advanced Biotherapy

 

IAVC 01: Latest Research on Antibody Discovery and Antibody-Based Therapy

Time: 08:30-11:20, September 13, 2024 (Friday); Place: Room 5B, 1st Floor, Nanjiao Hotel Shanghai

 

Chair

Dr. Kai Xu, Associate Professor, University of Maryland School of Medicine, USA

 

08:30-08:35

Chair's Introduction

08:35-09:00

Title: Antibodies Targeting Abeta Peptide and Tau Protein in Alzheimer's Disease
Dr. Buyong Ma, Professor, Engineering Research Center of Cell & Therapeutic Antibody (MOE), School of Pharmacy, Shanghai Jiao Tong University, China

09:00-09:25

Title: Antibody Increases Cardiac Contraction
Dr. Kai Xu, Associate Professor, University of Maryland School of Medicine, USA

09:25-09:50

Title: AK0610, A Protective Human Antibody Against Respiratory Syncytial Virus by Targeting a Prefusion Epitope Across Sites IV and V of the Viral Fusion Glycoproteins
Dr. Junming Yie, CSO, Shanghai Ark Biopharmaceuticals, China

09:50-10:15

Title: Severe Fever with Thrombocytopenia Syndrome Virus Infection and IL�\10 May Be a Potential Target for Reducing SFTS and COVID�\19 Mortality and Could Serve as a Prognostic or Therapeutic Target

Dr. Lee Keun Hwa, Professor, Hanyang University College of Medicine, South Korea

10:15-10:30

Coffee Break

10:30-10:55

Title: Genome Editing mRNA Nanotherapies Inhibit Cervical Cancer Progression and Regulate the Immunosuppressive Microenvironment for Adoptive T-cell Therapy

Dr. Kaijian Ling, Director, Department of Gynecology Women and Children Hospital, Hainan University, China

10:55-11:20

Title: NK Cell Engager for the Treatment of Solid Tumor
Dr. Yi (Gloria) Wang, Clinical Research Associate, Novartis Institutes for BioMedical Research (NIBR), China

 

IAVC 02: New Vaccines Design and Development

Time: 08:30-11:45, September 14, 2024 (Saturday); Place: Room 5B, 1st Floor, Nanjiao Hotel Shanghai

 

Chair

Dr. Jinhua Xiang, Research Scientist & Principal Investigator, VA HealthCare and University of Iowa , USA

 

08:30-08:35

Chair's Introduction

08:35-09:00

Title: Development of Recombinant Vesicular Stomatitis Virus (rVSV)-based Bivalent Vaccine Against SARS-CoV-2 and Influenza a Virus

Dr. Xiaojian Yao, Director, Laboratory of Molecular Human Retrovirology, University of Manitoba, Canada

09:00-09:25

Title: A Multi-Season Randomised Controlled Trial of Advax-adjuvanted Seasonal Influenza Vaccine in Participants with Chronic Disease or Older Age

Dr. Dimitar Sajkov, Research Director, Australian Respiratory and Sleep Medicine Institute, Australia

09:25-09:50

Title: Dengue Virus Serotype-specific Inhibition of T cell Responses Is Due to a Single Amino Acid Polymorphism in the Envelope Protein

Dr. Jinhua Xiang, Research Scientist & Principal Investigator, VA HealthCare and University of Iowa , USA

09:50-10:15

Title: Development of Improved Vaccine Adjuvants Based on the Natural and Synthetic Saponins

Dr. Dayun Zhao, Professor, Shanghai Jiao Tong University, China

10:15-10:30

Coffee Break

10:30-10:55

Title: A New Stratey for Vaccine Immune Evaluation System 
Dr. Chongyang Liang, Professor, School of Pharmaceutical Sciences, Jilin University, China

10:55-11:20

Title: Advancements in CRISPR-based Diagnostics

Dr. Fei Deng, Research Associate, University of New South Wales, Australia

11:20-11:45

Title: In Silico Identification of Novel Immunogenic Secreted Proteins of Mycoplasma Bovis from Secretome Data and Experimental Verification
Dr. Ihsanullah Shirani, Ph.D. Scholar, The State Key Laboratory of Agricultural Microbiology, China

 

Track 4: Frontiers of Protein and Peptide Technology and Industrial Application

 

PepCon 01: Advanced Technology and Industrial Application of Protein & Peptide

Time: 13:30-17:35, September 13, 2024 (Friday); Place: Room 5 B, 1st Floor, Nanjiao Hotel Shanghai

 

Chair

Dr. Yan Li, Associate Director of Bioinformatics, Center for Research Informatics, Biological Science Division, The University of Chicago, USA

Co-chair

Dr. Mohammad Uddin, Associate Professor, Mercer University College of Pharmacy, USA

 

13:30-13:35

Chair's Introduction

13:35-14:00

Title: Enrichment of Peptides Carrying Post-translational Modifications for Mass Spectrometry Analysis

Dr. Yiying Zhu, Director of Chemical Biology Core, Tsinghua University, China

14:00-14:25

Title: Cardiac Targeting Peptide: From Discovery to Applications

Dr. Maliha Zahid, Associate Professor/Senior Associate Consultant, Mayo Clinic, USA

14:25-14:50

Title: Automated CyTOF Data Analysis Application (ACDApp)

Dr. Yan Li, Associate Director of Bioinformatics, Center for Research Informatics, Biological Science Division, The University of Chicago, USA

14:50-15:15

Title: Revealing the Skin Peptidome of Ranid Frogs Using Mass Spectrometry as the Only Analytical Tool Revealing the Skin Peptidome

Dr. Albert Lebedev, Professor, Shenzhen MSU-BIT University, China

15:15-15:30

Coffee Break

15:30-15:55

Title: cGMP Commercial Scale Peptide Synthesizer: From Equipment Design Concept to System Qualification

Dr. Michael Li, Adjunct Professor, Suzhou University of Science and Technology, China

15:55-16:20

Title: Nanobody Conjugates Bearing Cyclic Cell-penetrating Peptide Modulate Protein Functions Inside Living Cells

Dr. Xi Chen, Principal Investigator, The HIT Center for Life Sciences, Harbin Institute of Technology, China

16:20-16:45

Title: The Application of Ultrasensitive Protein Microarray Technology in Biomarker Detection

Dr. Aiying Zhang, Professor, Beijing You-An Hospital, Capital Medical University, China

16:45-17:10

Title: A Novel Dual Action Antibiotic Adjuvant Strategy Using Ionic Liquid Towards Synergistic Restoration of Activity in MDRO and Enhancing Antimicrobial Activity against MRSA

Dr. Mohammad Uddin, Associate Professor, Mercer University College of Pharmacy, USA

17:10-17:35

Title: Are We Ready to Reclassify Crohn's Disease Using Molecular Classification?

Dr. Shahed Kamal, Medical Registrar, Northern Hospital, Australia

 

Track 5: Innovative Novel Enzyme Preparation and Industrialization

 

SEB 01: Emerging Technologies in Enzyme Discovery and Engineering

Time: 13:30-16:20, September 13, 2024 (Friday); Place: Room 6, 1st Floor, Nanjiao Hotel Shanghai

 

Chair

Dr. Weizhuo Xu, Associate Professor, Shenyang Pharmaceutical University, China

 

13:30-13:35

Chair's Introduction

13:35-14:00

Title: Biosynthesis of High-value Glycoside Functional Products

Dr. Hao Liang, Professor, Beijing University of Chemical Technology, China

14:00-14:25

Title: Assay of Lytic Polysaccharide Monooxygenase Activity in the Culture Supernatant of Recombinant Trichoderma reesei

Dr. Gang Liu, Professor, Shenzhen University, China

14:25-14:50

Title: Exploring of the Peroxidase Mechanism of Cytochrome c: From Mitochondrial Function to Biotechnological Applications

Dr. Danyun Zeng, Associate Professor, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences, China

14:50-15:15

Title: Biosynthesis of Vanillin by Rational Design of enoyl-CoA hydratase/lyase

Dr. Weizhuo Xu, Associate Professor, Shenyang Pharmaceutical University, China

15:15-15:30

Coffee Break

15:30-15:55

Title: Activation of Phospholipase A2 by Prostaglandin in vitro

Dr. Rohit Sood, Director, Spinverse Oy, Finland

15:55-16:20

Title: Family IV Carboxylesterases from Environmental Metagenomes and Bacterial Genomes for Polyesterase Activity

Ms. Hairong Ma, Bangor University, UK

 

Track 6: Advanced Diagnosis and Treatment of Diabetes and Obesity Metabolic Diseases

 

WCDO 01: Diabetes, Obesity and Metabolic Diseases

Time: 14:00-16:50, September 12, 2024 (Thursday); Place: Room 4, 1st Floor, Shanghai, China

 

Chair

Dr. Shunlin Ren, Associate Professor, Department of Internal Medicine, Virginia Commonwealth University, USA

 

14:00-14:05

Chair's Introduction

14:05-14:30

 

Title: System Genetic Approach Reveals the Role of Alox12 in Diet-Induced Obesity in BXD Mice
Dr. Lu Lu, Professor, Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, USA

14:30-14:55

Title: Early Diagnosis for Early Treatment in Cystic Fibrosis (CF)

Dr. Silvia Gartner, Professor, Hospital Universitari Vall d´Hebron. Barcleona, Spain

14:55-15:20

 

Title: 25HC3S: Endogenous Epigenetic Regulator for Treating Chronic & Acute Liver Diseases
Dr. Shunlin Ren, Professor, Department of Internal Medicine, Virginia Commonwealth University, USA

15:20-15:45

 

Title: Two Novel Candidate Genes Identified in Adults from the Newfoundland Population with Addictive Tendencies Towards Food
Dr. Guang Sun, Professor, Memorial University, Canada

15:45-16:00

Coffee Break

16:00-16:25

Title: Sorbs2 Deficiency and Coronary BK Channelopathy in Diabetes
Dr. Tong Lu, Associate Professor, Mayo Clinic, USA

16:25-16:50

Title: Decoding regeneration using computer designed proteins

Dr. Hannele Ruohola-Baker, Professor & Associate Director, Institute for Stem Cell and Regenerative Medicine (ISCRM), University of Washington, USA

 

Posters and Papers

01

Title: Creation Panel of Primary Breast Cancer Cell Lines as New Cancer Model for Drug Screening and Basic Research

Dr. Xiaowei Dou, Research Associate, Clinical Research Center, The Affiliated Hospital of Guizhou Medical University, China

02

Title: Novel pH-Responsive Peptide-Paclitaxcel Conjugate with Improved Therapeutic Potentials Against Glioblastoma

Dr. Syed Faheem Askari Rizvi, Postdoctoral Fellow, Lanzhou University, China

03

Title: Enhanced Detection of Ligand-PPARγ Binding Based on Surface Plasmon Resonance through Complexation with SRC1- or NCOR2-Related Polypeptide

Dr. Changzhen Liu, Professor, Experimental Research Center, China Academy of Chinese Medical Sciences, China

04

Title: Divergent Molecular Assembly and Catalytic Mechanisms between Bacterial and Archaeal RNase P in pre-tRNA Cleavage

Dr. Xiaoge Liang, Shanghai Jiao Tong University, China

05

Title: Disulfiram/Cu Increase the Anti-Tumor Response of Chemo-Immunotherapy by Targeting Pancreatic Cancer Stem Cells 
Dr. Yue Ding, Tongji University, China

06

Title: Development of Boron-Containing Multifunctional Nanoconstructs Based on Modified Forms of Albumin for Theranostics of Malignant Tumors

Ms. Meiling Wang, Novosibirsk State University, Russia

07

Title: Study on the Hypoglycemic Mechanism of Extracts from Rhinacanthus nasutus (L.) Kurz Based on Serum Pharmacochemistry, Network Pharmacology, And Experimental Verification

Ms. Junyu Liu, PhD.Candidate, Tianjin University, China

08

Title: Steam Explosion Improves Extractability, Antioxidant Activity and α-glucosidase Inhibitory Activity of the Constituents of Java Tea (Clerodendranthus Spicatus)

Ms. Jia Wang, PhD.Candidate, Tianjin University, China

09

Title: Two genes PA5178 and PA5489 Are Components of the Regulon for the ECF Sigma Factor AlgT/U in Pseudomonas Aeruginosa. A Close Look at Possibilities of up Regulating These Two Genes in an Alginate + or Mucoid Phenotype
Dr. Sonal Malhotra, Professor of Practice, DVIKAR, Gujarat University at Ahmedabad, India 

 

  

 



----------------------Contact Us----------------------
Add: Life Science Innovation Center BLD 3-2, 43 Torch Road, High Tech Park, Dalian, LN 116023, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright ? 2003-2024 BIT CONVENTION INC.